Literature DB >> 19173294

Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Nitin Nitin1, Alicia L Carlson, Tim Muldoon, Adel K El-Naggar, Ann Gillenwater, Rebecca Richards-Kortum.   

Abstract

The clinical value of assessing tumor glucose metabolism via F-18 fluorodeoxyglucose (FDG) PET imaging in oncology is well established; however, the poor spatial resolution of PET is a significant limitation especially for early stage lesions. An alternative technology is optical molecular imaging, which allows for subcellular spatial resolution and can be effectively used with topical contrast agents for imaging epithelial derived cancers. The goal of this study was to evaluate the potential of optical molecular imaging of glucose metabolism to aid in early detection of oral neoplasia. Fluorescently labeled deoxyglucose (2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose)) was applied topically to tissue phantoms, fresh oral biopsies (n = 32) and resected tumors specimens (n = 2). High-resolution imaging results show that 2-NBDG can be rapidly delivered to oral epithelium using topical application. In normal epithelium, the uptake of 2-NBDG is limited to basal epithelial cells. In contrast, high-grade dysplasia and cancers show uptake of 2-NBDG in neoplastic cells throughout the lesion. Following 2-NBDG labeling, the mean fluorescence intensity of neoplastic tissue averages 3.7 times higher than that of matched nonneoplastic oral biopsies in samples from 20 patients. Widefield fluorescence images of 8-paired oral specimens were obtained pre and postlabeling with 2-NBDG. Prior to labeling, neoplastic samples showed significantly lower autofluorescence than nonneoplastic samples. The fluorescence of neoplastic samples increased dramatically after labeling; the differential increase in fluorescence was on average 30 times higher in neoplastic samples than in normal samples. Topical application of 2-NBDG can therefore provide image contrast in both widefield and high-resolution fluorescence imaging modalities, highlighting its potential in early detection of oral neoplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19173294      PMCID: PMC2700039          DOI: 10.1002/ijc.24222

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Realistic three-dimensional epithelial tissue phantoms for biomedical optics.

Authors:  Konstantin Sokolov; Javier Galvan; Alexey Myakov; Alicia Lacy; Rueben Lotan; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2002-01       Impact factor: 3.170

Review 2.  Molecular imaging and cancer.

Authors:  Ronald G Blasberg
Journal:  Mol Cancer Ther       Date:  2003-03       Impact factor: 6.261

Review 3.  Molecular imaging in the clinical arena.

Authors:  Farouc A Jaffer; Ralph Weissleder
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

Review 4.  Glucose metabolism and cancer.

Authors:  Reuben J Shaw
Journal:  Curr Opin Cell Biol       Date:  2006-10-12       Impact factor: 8.382

5.  Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells.

Authors:  Roger G O'Neil; Ling Wu; Nizar Mullani
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

6.  Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers.

Authors:  Zhihong Zhang; Hui Li; Qian Liu; Lanlan Zhou; Min Zhang; Qingming Luo; Jerry Glickson; Britton Chance; Gang Zheng
Journal:  Biosens Bioelectron       Date:  2004-10-15       Impact factor: 10.618

Review 7.  PET imaging of cellular proliferation.

Authors:  David A Mankoff; Anthony F Shields; Kenneth A Krohn
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

8.  Fluorometric determination of glucose utilization in neurons in vitro and in vivo.

Authors:  Yoshiaki Itoh; Takato Abe; Rie Takaoka; Norio Tanahashi
Journal:  J Cereb Blood Flow Metab       Date:  2004-09       Impact factor: 6.200

9.  Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy.

Authors:  Timothy J Muldoon; Mark C Pierce; Dawn L Nida; Michelle D Williams; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Opt Express       Date:  2007-12-10       Impact factor: 3.894

Review 10.  Translational molecular imaging for cancer.

Authors:  Martin G Pomper
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

View more
  35 in total

1.  In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analog.

Authors:  Vassiliy Tsytsarev; Konstantin I Maslov; Junjie Yao; Archana R Parameswar; Alexei V Demchenko; Lihong V Wang
Journal:  J Neurosci Methods       Date:  2011-09-14       Impact factor: 2.390

2.  Endoscopic imaging: How far are we from real-time histology?

Authors:  Richa Shukla; Wasif M Abidi; Rebecca Richards-Kortum; Sharmila Anandasabapathy
Journal:  World J Gastrointest Endosc       Date:  2011-10-16

3.  Target-to-background enhancement in multispectral endoscopy with background autofluorescence mitigation for quantitative molecular imaging.

Authors:  Chenying Yang; Vivian W Hou; Emily J Girard; Leonard Y Nelson; Eric J Seibel
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

4.  Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan.

Authors:  Bilal Ghosn; Anne L van de Ven; Justina Tam; Ann Gillenwater; Konstantin V Sokolov; Rebecca Richards-Kortum; Krishnendu Roy
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

Review 5.  Cancer imaging by optical coherence tomography: preclinical progress and clinical potential.

Authors:  Benjamin J Vakoc; Dai Fukumura; Rakesh K Jain; Brett E Bouma
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

Review 6.  Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics.

Authors:  Anne Hellebust; Rebecca Richards-Kortum
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

7.  Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.

Authors:  Kelsey J Rosbach; Michelle D Williams; Ann M Gillenwater; Rebecca R Richards-Kortum
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

8.  Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.

Authors:  Zhen Luo; Rohan Vijay Tikekar; Kiana Michelle Samadzadeh; Nitin Nitin
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

9.  2-NBDG, a fluorescent analogue of glucose, as a marker for detecting cell electropermeabilization in vitro.

Authors:  Elham Raeisi; Lluis M Mir
Journal:  J Membr Biol       Date:  2012-08-11       Impact factor: 1.843

10.  Vital-dye-enhanced multimodal imaging of neoplastic progression in a mouse model of oral carcinogenesis.

Authors:  Anne Hellebust; Kelsey Rosbach; Jessica Keren Wu; Jennifer Nguyen; Ann Gillenwater; Nadarajah Vigneswaran; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2013-12       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.